Targeting ERK signalling to ameliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2

靶向 ERK 信号传导以改善与 16p11.2 染色体重排相关的智力障碍和自闭症谱系障碍

基本信息

  • 批准号:
    MR/S037667/1
  • 负责人:
  • 金额:
    $ 181.63万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    未结题

项目摘要

Human genetics has enabled us to identify specific gene variations which are associated with neurodevelopment disorders (NDD) such intellectual disability (ID) and Autism spectrum disorder (ASD). Just over 1% of the UK population are believed to be on the autism spectrum, meaning over 695,000 people in the UK may be autistic. Intellectual disability affects about 2-3% of the general population, with at least 25% of cases likely to be caused by a genetic predisposition.There is currently no cure for ASD/ID and no medications to treat the main symptoms of these disorders. This project aims to improve the chances of developing medicines able to reverse the effects of these genetic alterations. Among the most common genetic forms of ASD/ID lie chromosomal modifications, which cause either a deletion or a duplication of a group of genes. Interestingly, there are important differences between the duplication and the deletion patients such as metabolic changes (tendency to increase weight in the deletion and decrease weight in the duplication) and craniofacial abnormalities (deletion is associated with increased head size whereas the duplication is associated with decreased size). Importantly, duplication patients may be more susceptible to psychotic symptoms in addition to ID/ASD.In the 16p11.2 chromosomal region there are 27 distinct genes but we currently do not know their contribution to the pathological state. We have gathered strong preliminary evidence that one of these genes, MAPK3, may play a prominent role in the development of these ASD/ID forms associated to the 16p11.2 region. In this project, we will investigate the role of MAPK3 in both duplication and deletion patients by monitoring in the blood its activity. The goal is to be able to use MAPK3 as a tool to help both diagnosis and future treatments.We will also generate sophisticated human cellular models and mini-brain preparations to study how MAPK3 levels can be corrected and possibly restored using novel experimental drugs.At the end of the project we will have demonstrate whether MAPK3 is a valid therapeutic target for the diagnosis and the treatment of 16p11.2 duplication and deletion patients.
人类遗传学使我们能够识别与神经发育障碍(NDD)相关的特定基因变异,如智力残疾(ID)和自闭症谱系障碍(ASD)。据信,英国只有1%以上的人口属于自闭症谱系,这意味着英国可能有超过695,000人患有自闭症。智力残疾影响大约2-3%的普通人群,其中至少25%的病例可能是由遗传易感性引起的。目前没有治疗ASD/ID的方法,也没有治疗这些疾病的主要症状的药物。该项目旨在提高开发能够逆转这些基因改变影响的药物的机会。ASD/ID最常见的遗传形式之一是染色体修饰,其导致一组基因的缺失或复制。有趣的是,重复和缺失患者之间存在重要差异,例如代谢变化(缺失中体重增加和重复中体重减少的趋势)和颅面异常(缺失与头部大小增加相关,而重复与大小减少相关)。重要的是,重复患者可能更容易患上精神病症状,除了ID/ASD。在16p11.2染色体区域有27个不同的基因,但我们目前不知道他们的病理状态的贡献。我们已经收集了强有力的初步证据表明,这些基因之一,MAPK 3,可能在这些ASD/ID形式的发展中发挥了突出的作用与16p11.2区域。在这个项目中,我们将通过监测血液中MAPK 3的活性来研究MAPK 3在重复和缺失患者中的作用。我们的目标是能够使用MAPK 3作为一种工具,以帮助诊断和未来的治疗。在项目的最后,我们将证明MAPK 3是否是诊断和治疗16p11.2重复的有效治疗靶点和缺失型患者。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l-Dopa-induced dyskinesia.
G 蛋白信号传导调节器 4 (RGS4) 负向调节伤害感受肽/孤啡肽 FQ 阿片受体信号传导:对左旋多巴诱导的运动障碍的影响。
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice.
  • DOI:
    10.3389/fphar.2022.986566
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
  • 通讯作者:
Dopamine D1 and Glutamate Receptors Co-operate With Brain-Derived Neurotrophic Factor (BDNF) and TrkB to Modulate ERK Signaling in Adult Striatal Slices.
  • DOI:
    10.3389/fncel.2020.564106
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Morella I;Hallum H;Brambilla R
  • 通讯作者:
    Brambilla R
An adapted social communication intervention at home and education to promote social communication change in children with severe autism: the PACT-G RCT
适应家庭和教育的社会沟通干预,以促进严重自闭症儿童的社会沟通改变:PACT-G RCT
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Riccardo Brambilla其他文献

Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements
神经营养因子 3 受体基因 trkC 的破坏消除了 la 肌肉传入纤维并导致异常运动
  • DOI:
    10.1038/368249a0
  • 发表时间:
    1994-03-17
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Rüdiger Klein;Inmaculada Silos-Santiago;Richard J. Smeyne;Sergio A. Lira;Riccardo Brambilla;Sherri Bryant;Li Zhang;William D. Snider;Mariano Barbacid
  • 通讯作者:
    Mariano Barbacid
Edible energy: balancing inputs and waste in food supply chain and biofuels from algae
  • DOI:
    10.1140/epjp/i2017-11301-8
  • 发表时间:
    2017-01-16
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Gianluca Alimonti;Riccardo Brambilla;Rosaria Pileci;Riccardo Romano;Francesca Rosa;Luca Spinicci
  • 通讯作者:
    Luca Spinicci
Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator.
通过编码 CDC25(一种酿酒酵母 RAS 激活剂)同源物的小鼠 cDNA 进行功能互补克隆。
  • DOI:
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    E. Martegani;Marco Vanoni;R. Zippel;Paola Coccetti;Riccardo Brambilla;Cristina Ferrari;Emmapaola Sturani;Lilia Alberghina
  • 通讯作者:
    Lilia Alberghina
891. Correction of Established Neurologic Disease and Evidences of In Vivo Cross Correction in the Mouse Model of Metachromatic Leukodystrophy
  • DOI:
    10.1016/j.ymthe.2006.08.980
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Alessandra Biffi;Alessia Capotondo;Stefania Fasano;Ubaldo del Carro;Sergio Marchesini;Hisaya Azuma;Riccardo Brambilla;Markus Grompe;Claudio Bordignon;Angelo Quattrini;Luigi Naldini
  • 通讯作者:
    Luigi Naldini
Knockout of ERK1 Enhances Cocaine-Evoked Immediate Early Gene Expression and Behavioral Plasticity
ERK1 基因敲除增强可卡因诱发的即刻早期基因表达和行为可塑性
  • DOI:
    10.1038/sj.npp.1301014
  • 发表时间:
    2006-01-11
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Susan M Ferguson;Stefania Fasano;Pengwei Yang;Riccardo Brambilla;Terry E Robinson
  • 通讯作者:
    Terry E Robinson

Riccardo Brambilla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

毛兰素通过MEK/ERK信号通路调控谷氨酰胺代谢重编程抑制子宫内膜癌的作用及分子机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
EZH2通过RAF1-MEK/ERK信号通路调节小胶质细胞脂代谢重编程影响阿尔茨海默病中斑块沉积的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
GOLPH3调控ERK/MMP2/9通路保护糖萼维持急性肺损伤时肺泡上皮屏障功能的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
姜黄素调控Oxtr/ERK5通路治疗子宫腺肌病疼痛的作用与机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
ERK、Nrf2/HO-1铁死亡通路介导脂肪干 细胞改善衰老睾丸间质细胞功能的作用 及机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
紫檀芪通过DAPK1/ERK通路抑制慢性间歇性缺氧诱导的胶质细胞炎症反应的研究
  • 批准号:
    JCZRYB202500961
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
TRPC6-ERK1/2-LONP1通路介导的线粒体自噬障碍在FSGS足细胞损伤中的作用及机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
生育三烯酚调节RAS-ERK-MAPK通路促糖尿病溃疡愈合的机制研究
  • 批准号:
    2025JJ80977
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
芍药甘草汤酸甘相配调控ASIC3/ERK/AQP3通路改善慢传输型便秘的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于BDNF/TrkB/ERK1/2介导少突胶质细胞生成髓鞘研究电针改善脊髓损伤后运动功能障碍的机制
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Regulation of the oncogenic potential of signalling through the Ras/ERK pathway by dual-specificity phosphatase 5
双特异性磷酸酶 5 通过 Ras/ERK 途径调节信号传导的致癌潜力
  • 批准号:
    MR/N020790/1
  • 财政年份:
    2016
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Grant
The role of dual-specificity phosphatase 6 (DUSP6) in modulating the oncogenic potential of Ras/ERK signalling
双特异性磷酸酶 6 (DUSP6) 在调节 Ras/ERK 信号传导致癌潜力中的作用
  • 批准号:
    287328325
  • 财政年份:
    2015
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Fellowships
Structural insight into the ERK MAP kinase signalling cascade
ERK MAP 激酶信号级联的结构洞察
  • 批准号:
    255039
  • 财政年份:
    2012
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Studentship Programs
Regulation and role of the ERK signalling in colorectal carcinogenesis
ERK信号在结直肠癌发生中的调节和作用
  • 批准号:
    238696
  • 财政年份:
    2011
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Operating Grants
Middle T Antigen of Polyoma Virus-Mediated Activation of the Ras/Raf/MEK/ERK and Phosphoinositide 3-Kinase/Akt Signalling Pathways, and the Subsequent Effects on Gap Junctional Intercellular Communication
多瘤病毒中 T 抗原介导的 Ras/Raf/MEK/ERK 和磷酸肌醇 3-激酶/Akt 信号通路的激活以及对间隙连接细胞间通讯的后续影响
  • 批准号:
    200186
  • 财政年份:
    2010
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Studentship Programs
Regulation of ERK Signalling by the Scaffold Protein KSR1
支架蛋白 KSR1 对 ERK 信号传导的调节
  • 批准号:
    G0600790/2
  • 财政年份:
    2008
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Grant
Crosstalk between cAMP and ERK signalling pathways in tubulogenesis
肾小管发生中 cAMP 和 ERK 信号通路之间的串扰
  • 批准号:
    73357210
  • 财政年份:
    2008
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Fellowships
Investigating FGF ERK MAP kinase signalling in vertebrate skeletal muscle differentiation
研究脊椎动物骨骼肌分化中的 FGF ERK MAP 激酶信号传导
  • 批准号:
    G0600757/1
  • 财政年份:
    2007
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Grant
Regulation of ERK Signalling by the Scaffold Protein KSR1
支架蛋白 KSR1 对 ERK 信号传导的调节
  • 批准号:
    G0600790/1
  • 财政年份:
    2007
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Grant
Perturbation of Ras-Erk and phosphatidylinositol 3-kinase signalling pathways by the hepatitis C virus NS5A protein
丙型肝炎病毒 NS5A 蛋白对 Ras-Erk 和磷脂酰肌醇 3 激酶信号通路的干扰
  • 批准号:
    G0401577/1
  • 财政年份:
    2006
  • 资助金额:
    $ 181.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了